Moreover, orthovanadate, that inhibits PTEN activation, reverts the sorafenib-induced apoptosis in BC cells, suggesting that sorafenib-induced CB tyrosine dephosphorylation represents a requisite to obtain the necessary CB enzymatic activity required to stimulate apoptosis in BC cells.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}